25909158 32772367 26149921 28803412 31055836 26666838 36527982 30862700 29433982 33373595 26824991 27280685 30045977 25785645 28030591 28232892 30288630 34772429 25471588 35244787 29680709 24314025 24664141 35260646 32796544 31728405 24471711 2945390 - Search Results

Year	Number of Results
2013	1
2014	3
2015	6
2016	7
2017	1
2018	6
2019	6
2020	4
2021	4
2022	5
2023	1

1

Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.

Stefanovic AN, Lindhoud S, Semerdzhiev SA, Claessens MM, Subramaniam V. Stefanovic AN, et al. Biochemistry. 2015 May 26;54(20):3142-50. doi: 10.1021/bi501369k. Epub 2015 May 14. Biochemistry. 2015. PMID: 25909158

2

Monitoring alpha-synuclein oligomerization and aggregation using bimolecular fluorescence complementation assays: What you see is not always what you get.

Frey B, AlOkda A, Jackson MP, Riguet N, Duce JA, Lashuel HA. Frey B, et al. J Neurochem. 2021 May;157(4):872-888. doi: 10.1111/jnc.15147. Epub 2020 Oct 27. J Neurochem. 2021. PMID: 32772367 Free PMC article.

3

Increased oligomerization and phosphorylation of α-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains.

Liu G, Chen M, Mi N, Yang W, Li X, Wang P, Yin N, Li Y, Yue F, Chan P, Yu S. Liu G, et al. Neurobiol Aging. 2015 Sep;36(9):2649-59. doi: 10.1016/j.neurobiolaging.2015.06.004. Epub 2015 Jun 11. Neurobiol Aging. 2015. PMID: 26149921

4

Alpha-synuclein oligomers: a new hope.

Bengoa-Vergniory N, Roberts RF, Wade-Martins R, Alegre-Abarrategui J. Bengoa-Vergniory N, et al. Acta Neuropathol. 2017 Dec;134(6):819-838. doi: 10.1007/s00401-017-1755-1. Epub 2017 Aug 12. Acta Neuropathol. 2017. PMID: 28803412 Free PMC article. Review.

5

Antibodies against alpha-synuclein: tools and therapies.

Vaikath NN, Hmila I, Gupta V, Erskine D, Ingelsson M, El-Agnaf OMA. Vaikath NN, et al. J Neurochem. 2019 Sep;150(5):612-625. doi: 10.1111/jnc.14713. Epub 2019 Jun 25. J Neurochem. 2019. PMID: 31055836 Free article. Review.

6

Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.

Rey NL, George S, Brundin P. Rey NL, et al. Neuropathol Appl Neurobiol. 2016 Feb;42(1):51-76. doi: 10.1111/nan.12299. Neuropathol Appl Neurobiol. 2016. PMID: 26666838 Review.

7

Monitoring α-synuclein aggregation.

Estaun-Panzano J, Arotcarena ML, Bezard E. Estaun-Panzano J, et al. Neurobiol Dis. 2023 Jan;176:105966. doi: 10.1016/j.nbd.2022.105966. Epub 2022 Dec 15. Neurobiol Dis. 2023. PMID: 36527982 Free PMC article. Review.

8

Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein.

Harischandra DS, Rokad D, Neal ML, Ghaisas S, Manne S, Sarkar S, Panicker N, Zenitsky G, Jin H, Lewis M, Huang X, Anantharam V, Kanthasamy A, Kanthasamy AG. Harischandra DS, et al. Sci Signal. 2019 Mar 12;12(572):eaau4543. doi: 10.1126/scisignal.aau4543. Sci Signal. 2019. PMID: 30862700 Free PMC article.

9

Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice.

Cai W, Feng D, Schwarzschild MA, McLean PJ, Chen X. Cai W, et al. EBioMedicine. 2018 Mar;29:13-22. doi: 10.1016/j.ebiom.2018.01.035. Epub 2018 Jan 31. EBioMedicine. 2018. PMID: 29433982 Free PMC article.

10

Interactions of α-synuclein oligomers with lipid membranes.

Musteikytė G, Jayaram AK, Xu CK, Vendruscolo M, Krainer G, Knowles TPJ. Musteikytė G, et al. Biochim Biophys Acta Biomembr. 2021 Apr 1;1863(4):183536. doi: 10.1016/j.bbamem.2020.183536. Epub 2020 Dec 26. Biochim Biophys Acta Biomembr. 2021. PMID: 33373595 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results